Evaluating a new injectable contraceptive for women

Who could benefit from this research

What this research studies

This research investigates a new long-acting injectable contraceptive called levonorgestrel butanoate, designed specifically for women, particularly those who are obese and at risk for venous thromboembolism (VTE). The study aims to provide an estrogen-free alternative to traditional contraceptive methods, which often require strict adherence and may pose additional health risks. By conducting a clinical trial, the researchers will assess the efficacy and safety of this new formulation, making it easier for women to manage their contraceptive needs without the associated risks of estrogen. The trial will gather data on how well this new contraceptive works and its potential benefits for women in the target demographic.

Why it matters

Where this research is happening

• Oregon Health & Science University
  Portland, United States Active

Researchers

• Principal investigator: Jensen, Jeffrey — Oregon Health & Science University
• Study coordinator: Jensen, Jeffrey

Related research

Other NIH-funded projects on the same topics.

• Mobile health support to boost PrEP and contraception use among young women in Zambia

  A mobile health program helps female university students in Zambia learn about and access HIV prevention and contraception.

  NIH research University of Colorado Denver · Aurora, UNITED STATES · NIH-11570031

• A woman-controlled, nonhormonal on-demand contraceptive device

  This project is creating a woman-controlled vaginal device that releases a fabric-like polymer which thickens on contact with semen to help prevent pregnancy.

  NIH research St. Louis College of Pharmacy · St. Louis, UNITED STATES · NIH-11478955

• Mobile health tool to boost PrEP and contraception use among female university students in Zambia

  A mobile, peer-supported program helps young women in Zambia start and stick with PrEP and modern contraception to prevent HIV and unintended pregnancy.

  NIH research University of Colorado Denver · Aurora, UNITED STATES · NIH-11385413

• Evaluating a new injectable contraceptive for women

  This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, especially for women who are overweight and at risk for blood clots, to see if it works well and is safe without the added hormones found in other methods.

  NIH research University of Utah · Salt Lake City, United States · NIH-11337219

• Evaluating a new injectable contraceptive for women

  This study is testing a new long-lasting birth control shot called levonorgestrel butanoate, which is made for women, especially those who are overweight and may have a higher risk of blood clots, to see how well it works and how it moves through the body, while offering a safer and easier option than taking a pill eve

  NIH research Health Decisions, INC. · Morrisville, United States · NIH-11251139

• Tablet-based peer support to help female university students in Zambia use PrEP and contraception

  A tablet-led peer navigator program to help female university students in Zambia learn about and start using PrEP and modern contraception.

  NIH research University of Colorado Denver · Aurora, UNITED STATES · NIH-11178682

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.